 | • レポートコード：MRC2102QY2875 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の水痘（水疱瘡）ワクチン市場について種類別（一価ワクチン、混合ワクチン）、用途別（キッズ注射、大人注射）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・水痘（水疱瘡）ワクチン市場の概要 ・世界の主要地域別水痘（水疱瘡）ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の水痘（水疱瘡）ワクチン市場規模2015-2026：種類別（一価ワクチン、混合ワクチン） ・世界の水痘（水疱瘡）ワクチン市場規模2015-2026：用途別（キッズ注射、大人注射） ・水痘（水疱瘡）ワクチンの米国市場規模2015-2020 ・水痘（水疱瘡）ワクチンのヨーロッパ市場規模2015-2020 ・水痘（水疱瘡）ワクチンの中国市場規模2015-2020 ・水痘（水疱瘡）ワクチンの日本市場規模2015-2020 ・水痘（水疱瘡）ワクチンの東南アジア市場規模2015-2020 ・水痘（水疱瘡）ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・水痘（水疱瘡）ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・水痘（水疱瘡）ワクチンの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Chickenpox (Varicella) Vaccine Market
The global Chickenpox (Varicella) Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Chickenpox (Varicella) Vaccine Scope and Market Size
The global Chickenpox (Varicella) Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chickenpox (Varicella) Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Chickenpox (Varicella) Vaccine market is segmented into
Monovalent Vaccine
Combination Vaccine
Segment by Application, the Chickenpox (Varicella) Vaccine market is segmented into
Kids Injection
Adults Injection
The Chickenpox (Varicella) Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Chickenpox (Varicella) Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chickenpox (Varicella) Vaccine Market Share Analysis
Chickenpox (Varicella) Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chickenpox (Varicella) Vaccine business, the date to enter into the Chickenpox (Varicella) Vaccine market, Chickenpox (Varicella) Vaccine product introduction, recent developments, etc.
The major vendors covered:
Merck & Co.
Sanofi Pasteur
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
1 Chickenpox (Varicella) Vaccine Market Overview
1.1 Chickenpox (Varicella) Vaccine Product Scope
1.2 Chickenpox (Varicella) Vaccine Segment by Type
1.2.1 Global Chickenpox (Varicella) Vaccine Sales by Type (2020-2026)
1.2.2 Monovalent Vaccine
1.2.3 Combination Vaccine
1.3 Chickenpox (Varicella) Vaccine Segment by Application
1.3.1 Global Chickenpox (Varicella) Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Chickenpox (Varicella) Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Chickenpox (Varicella) Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Chickenpox (Varicella) Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Chickenpox (Varicella) Vaccine Price Trends (2015-2026)
2 Chickenpox (Varicella) Vaccine Estimate and Forecast by Region
2.1 Global Chickenpox (Varicella) Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Chickenpox (Varicella) Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Chickenpox (Varicella) Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Chickenpox (Varicella) Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Chickenpox (Varicella) Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Chickenpox (Varicella) Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Chickenpox (Varicella) Vaccine Estimates and Projections (2015-2026)
2.4.3 China Chickenpox (Varicella) Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Chickenpox (Varicella) Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Chickenpox (Varicella) Vaccine Estimates and Projections (2015-2026)
2.4.6 India Chickenpox (Varicella) Vaccine Estimates and Projections (2015-2026)
3 Global Chickenpox (Varicella) Vaccine Competition Landscape by Players
3.1 Global Top Chickenpox (Varicella) Vaccine Players by Sales (2015-2020)
3.2 Global Top Chickenpox (Varicella) Vaccine Players by Revenue (2015-2020)
3.3 Global Chickenpox (Varicella) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chickenpox (Varicella) Vaccine as of 2019)
3.4 Global Chickenpox (Varicella) Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Chickenpox (Varicella) Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Chickenpox (Varicella) Vaccine Players (Opinion Leaders)
4 Global Chickenpox (Varicella) Vaccine Market Size by Type
4.1 Global Chickenpox (Varicella) Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Chickenpox (Varicella) Vaccine Price by Type (2015-2020)
4.2 Global Chickenpox (Varicella) Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Chickenpox (Varicella) Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Chickenpox (Varicella) Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Chickenpox (Varicella) Vaccine Price Forecast by Type (2021-2026)
5 Global Chickenpox (Varicella) Vaccine Market Size by Application
5.1 Global Chickenpox (Varicella) Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Chickenpox (Varicella) Vaccine Price by Application (2015-2020)
5.2 Global Chickenpox (Varicella) Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Chickenpox (Varicella) Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Chickenpox (Varicella) Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Chickenpox (Varicella) Vaccine Price Forecast by Application (2021-2026)
6 United States Chickenpox (Varicella) Vaccine Market Facts & Figures
6.1 United States Chickenpox (Varicella) Vaccine Sales Market Share by Company (2015-2020)
6.2 United States Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
6.3 United States Chickenpox (Varicella) Vaccine Sales Market Share by Application (2015-2020)
7 Europe Chickenpox (Varicella) Vaccine Market Facts & Figures
7.1 Europe Chickenpox (Varicella) Vaccine Sales Market Share by Company (2015-2020)
7.2 Europe Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
7.3 Europe Chickenpox (Varicella) Vaccine Sales Market Share by Application (2015-2020)
8 China Chickenpox (Varicella) Vaccine Market Facts & Figures
8.1 China Chickenpox (Varicella) Vaccine Sales Market Share by Company (2015-2020)
8.2 China Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
8.3 China Chickenpox (Varicella) Vaccine Sales Market Share by Application (2015-2020)
9 Japan Chickenpox (Varicella) Vaccine Market Facts & Figures
9.1 Japan Chickenpox (Varicella) Vaccine Sales Market Share by Company (3015-3030)
9.2 Japan Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
9.3 Japan Chickenpox (Varicella) Vaccine Sales Market Share by Application (2015-2020)
10 Southeast Asia Chickenpox (Varicella) Vaccine Market Facts & Figures
10.1 Southeast Asia Chickenpox (Varicella) Vaccine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Chickenpox (Varicella) Vaccine Sales Market Share by Application (2015-2020)
11 India Chickenpox (Varicella) Vaccine Market Facts & Figures
11.1 India Chickenpox (Varicella) Vaccine Sales Market Share by Company (2015-2020)
11.2 India Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
11.3 India Chickenpox (Varicella) Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Chickenpox (Varicella) Vaccine Business
12.1 Merck & Co.
12.1.1 Merck & Co. Corporation Information
12.1.2 Merck & Co. Business Overview
12.1.3 Merck & Co. Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck & Co. Chickenpox (Varicella) Vaccine Products Offered
12.1.5 Merck & Co. Recent Development
12.2 Sanofi Pasteur
12.2.1 Sanofi Pasteur Corporation Information
12.2.2 Sanofi Pasteur Business Overview
12.2.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Products Offered
12.2.5 Sanofi Pasteur Recent Development
12.3 GSK
12.3.1 GSK Corporation Information
12.3.2 GSK Business Overview
12.3.3 GSK Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GSK Chickenpox (Varicella) Vaccine Products Offered
12.3.5 GSK Recent Development
12.4 Shanghai Institute
12.4.1 Shanghai Institute Corporation Information
12.4.2 Shanghai Institute Business Overview
12.4.3 Shanghai Institute Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Shanghai Institute Chickenpox (Varicella) Vaccine Products Offered
12.4.5 Shanghai Institute Recent Development
12.5 BCHT
12.5.1 BCHT Corporation Information
12.5.2 BCHT Business Overview
12.5.3 BCHT Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 BCHT Chickenpox (Varicella) Vaccine Products Offered
12.5.5 BCHT Recent Development
12.6 Changsheng
12.6.1 Changsheng Corporation Information
12.6.2 Changsheng Business Overview
12.6.3 Changsheng Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Changsheng Chickenpox (Varicella) Vaccine Products Offered
12.6.5 Changsheng Recent Development
12.7 Keygen
12.7.1 Keygen Corporation Information
12.7.2 Keygen Business Overview
12.7.3 Keygen Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Keygen Chickenpox (Varicella) Vaccine Products Offered
12.7.5 Keygen Recent Development
12.8 Green Cross
12.8.1 Green Cross Corporation Information
12.8.2 Green Cross Business Overview
12.8.3 Green Cross Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Green Cross Chickenpox (Varicella) Vaccine Products Offered
12.8.5 Green Cross Recent Development
12.9 Biken
12.9.1 Biken Corporation Information
12.9.2 Biken Business Overview
12.9.3 Biken Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Biken Chickenpox (Varicella) Vaccine Products Offered
12.9.5 Biken Recent Development
13 Chickenpox (Varicella) Vaccine Manufacturing Cost Analysis
13.1 Chickenpox (Varicella) Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Chickenpox (Varicella) Vaccine
13.4 Chickenpox (Varicella) Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Chickenpox (Varicella) Vaccine Distributors List
14.3 Chickenpox (Varicella) Vaccine Customers
15 Market Dynamics
15.1 Chickenpox (Varicella) Vaccine Market Trends
15.2 Chickenpox (Varicella) Vaccine Opportunities and Drivers
15.3 Chickenpox (Varicella) Vaccine Market Challenges
15.4 Chickenpox (Varicella) Vaccine Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Chickenpox (Varicella) Vaccine Sales (K Doses) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Chickenpox (Varicella) Vaccine Sales (K Doses) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Chickenpox (Varicella) Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Chickenpox (Varicella) Vaccine Sales (K Doses) by Region (2015-2020)
Table 5. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Chickenpox (Varicella) Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Chickenpox (Varicella) Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 9. Global Chickenpox (Varicella) Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Chickenpox (Varicella) Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Chickenpox (Varicella) Vaccine (K Doses) of Key Companies (2015-2020)
Table 13. Global Chickenpox (Varicella) Vaccine Sales Share by Company (2015-2020)
Table 14. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Chickenpox (Varicella) Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Chickenpox (Varicella) Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chickenpox (Varicella) Vaccine as of 2019)
Table 17. Global Chickenpox (Varicella) Vaccine Average Price (USD/dose) of Key Company (2015-2020)
Table 18. Manufacturers Chickenpox (Varicella) Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Chickenpox (Varicella) Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Chickenpox (Varicella) Vaccine Players
Table 22. Global Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2015-2020)
Table 23. Global Chickenpox (Varicella) Vaccine Sales Share by Type (2015-2020)
Table 24. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Chickenpox (Varicella) Vaccine Price (K Doses) by Type (2015-2020)
Table 26. Global Chickenpox (Varicella) Vaccine Sales Share by Type (2021-2026)
Table 27. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Chickenpox (Varicella) Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Chickenpox (Varicella) Vaccine Price (K Doses) by Type (2021-2026)
Table 30. Global Chickenpox (Varicella) Vaccine Sales (K Doses) by Application (2015-2020)
Table 31. Global Chickenpox (Varicella) Vaccine Sales Share by Application (2015-2020)
Table 32. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Chickenpox (Varicella) Vaccine Price (K Doses) by Application (2015-2020)
Table 34. Global Chickenpox (Varicella) Vaccine Sales (K Doses) by Application (2021-2026)
Table 35. Global Chickenpox (Varicella) Vaccine Sales Share by Application (2021-2026)
Table 36. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Chickenpox (Varicella) Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Chickenpox (Varicella) Vaccine Price (K Doses) by Application (2021-2026)
Table 39. United States Chickenpox (Varicella) Vaccine Sales (K Doses) by Company (2015-2020)
Table 40. United States Chickenpox (Varicella) Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2015-2020)
Table 42. United States Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Chickenpox (Varicella) Vaccine Sales (K Doses) by Application (2015-2020)
Table 44. United States Chickenpox (Varicella) Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Chickenpox (Varicella) Vaccine Sales (K Doses) by Company (2015-2020)
Table 46. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2015-2020)
Table 48. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Chickenpox (Varicella) Vaccine Sales (K Doses) by Application (2015-2020)
Table 50. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Chickenpox (Varicella) Vaccine Sales (K Doses) by Company (2015-2020)
Table 52. China Chickenpox (Varicella) Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2015-2020)
Table 54. China Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Chickenpox (Varicella) Vaccine Sales (K Doses) by Application (2015-2020)
Table 56. China Chickenpox (Varicella) Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Chickenpox (Varicella) Vaccine Sales (K Doses) by Company (2015-2020)
Table 58. Japan Chickenpox (Varicella) Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2015-2020)
Table 60. Japan Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Chickenpox (Varicella) Vaccine Sales (K Doses) by Application (2015-2020)
Table 62. Japan Chickenpox (Varicella) Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Chickenpox (Varicella) Vaccine Sales (K Doses) by Company (2015-2020)
Table 64. Southeast Asia Chickenpox (Varicella) Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2015-2020)
Table 66. Southeast Asia Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2015-2020)
Table 68. Southeast Asia Chickenpox (Varicella) Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Chickenpox (Varicella) Vaccine Sales (K Doses) by Company (2015-2020)
Table 70. India Chickenpox (Varicella) Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2015-2020)
Table 72. India Chickenpox (Varicella) Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Chickenpox (Varicella) Vaccine Sales (K Doses) by Application (2015-2020)
Table 74. India Chickenpox (Varicella) Vaccine Sales Market Share by Application (2015-2020)
Table 75. Merck & Co. Corporation Information
Table 76. Merck & Co. Description and Business Overview
Table 77. Merck & Co. Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2015-2020)
Table 78. Merck & Co. Chickenpox (Varicella) Vaccine Product
Table 79. Merck & Co. Recent Development
Table 80. Sanofi Pasteur Corporation Information
Table 81. Sanofi Pasteur Description and Business Overview
Table 82. Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2015-2020)
Table 83. Sanofi Pasteur Chickenpox (Varicella) Vaccine Product
Table 84. Sanofi Pasteur Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2015-2020)
Table 88. GSK Chickenpox (Varicella) Vaccine Product
Table 89. GSK Recent Development
Table 90. Shanghai Institute Corporation Information
Table 91. Shanghai Institute Description and Business Overview
Table 92. Shanghai Institute Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2015-2020)
Table 93. Shanghai Institute Chickenpox (Varicella) Vaccine Product
Table 94. Shanghai Institute Recent Development
Table 95. BCHT Corporation Information
Table 96. BCHT Description and Business Overview
Table 97. BCHT Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2015-2020)
Table 98. BCHT Chickenpox (Varicella) Vaccine Product
Table 99. BCHT Recent Development
Table 100. Changsheng Corporation Information
Table 101. Changsheng Description and Business Overview
Table 102. Changsheng Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2015-2020)
Table 103. Changsheng Chickenpox (Varicella) Vaccine Product
Table 104. Changsheng Recent Development
Table 105. Keygen Corporation Information
Table 106. Keygen Description and Business Overview
Table 107. Keygen Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2015-2020)
Table 108. Keygen Chickenpox (Varicella) Vaccine Product
Table 109. Keygen Recent Development
Table 110. Green Cross Corporation Information
Table 111. Green Cross Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2015-2020)
Table 112. Green Cross Description and Business Overview
Table 113. Green Cross Chickenpox (Varicella) Vaccine Product
Table 114. Green Cross Recent Development
Table 115. Biken Corporation Information
Table 116. Biken Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2015-2020)
Table 117. Biken Description and Business Overview
Table 118. Biken Chickenpox (Varicella) Vaccine Product
Table 119. Biken Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Chickenpox (Varicella) Vaccine Distributors List
Table 123. Chickenpox (Varicella) Vaccine Customers List
Table 124. Chickenpox (Varicella) Vaccine Market Key Trends
Table 125. Chickenpox (Varicella) Vaccine Key Opportunities and Drivers
Table 126. Chickenpox (Varicella) Vaccine Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Chickenpox (Varicella) Vaccine Product Picture
Figure 2. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Chickenpox (Varicella) Vaccine Market Share by Application in 2020 & 2026
Figure 6. Kids Injection Examples
Figure 7. Adults Injection Examples
Figure 8. Global Chickenpox (Varicella) Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Chickenpox (Varicella) Vaccine Price Trends Growth Rate (2015-2026) (USD/dose)
Figure 11. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Chickenpox (Varicella) Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Chickenpox (Varicella) Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Chickenpox (Varicella) Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Chickenpox (Varicella) Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Chickenpox (Varicella) Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Chickenpox (Varicella) Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Chickenpox (Varicella) Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Chickenpox (Varicella) Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Chickenpox (Varicella) Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Chickenpox (Varicella) Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Chickenpox (Varicella) Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Chickenpox (Varicella) Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Chickenpox (Varicella) Vaccine Players Market Share by Revenue in Chickenpox (Varicella) Vaccine 2015 & 2019
Figure 26. Chickenpox (Varicella) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Chickenpox (Varicella) Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Chickenpox (Varicella) Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Chickenpox (Varicella) Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Chickenpox (Varicella) Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Chickenpox (Varicella) Vaccine Sales Market Share by Type in 2019
Figure 32. United States Chickenpox (Varicella) Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Application in 2019
Figure 36. China Chickenpox (Varicella) Vaccine Sales Market Share by Company in 2019
Figure 37. China Chickenpox (Varicella) Vaccine Sales Market Share by Type in 2019
Figure 38. China Chickenpox (Varicella) Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Chickenpox (Varicella) Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Chickenpox (Varicella) Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Chickenpox (Varicella) Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Chickenpox (Varicella) Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Chickenpox (Varicella) Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Chickenpox (Varicella) Vaccine Sales Market Share by Application in 2019
Figure 45. India Chickenpox (Varicella) Vaccine Sales Market Share by Company in 2019
Figure 46. India Chickenpox (Varicella) Vaccine Sales Market Share by Type in 2019
Figure 47. India Chickenpox (Varicella) Vaccine Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Chickenpox (Varicella) Vaccine
Figure 50. Manufacturing Process Analysis of Chickenpox (Varicella) Vaccine
Figure 51. Chickenpox (Varicella) Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
弱毒生水痘ワクチンの世界市場レポート2020 A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella. The downstream industries of varicella attenuated live vaccine products are kids and adults. In the recent years, with the recovery of global economic, the development of em…- 水痘ワクチンの世界市場レポート2020 Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to c…
- 麻疹（はしか）ワクチンの世界市場レポート2020 Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles. Market Analysis and Insights: Global Measl…
- ヒト用ワクチンの世界市場レポート2020 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. China …
- インフルエンザワクチンの世界市場レポート2020 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…